GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 428.96
+11.79 (2.83%)
At close: Jan 16, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 136.61 billion as of January 16, 2026. Its market cap has increased by 8.07% in one year.
Market Cap
136.61B
Enterprise Value
129.97B
Revenue
62.07B
Ranking
n/a
PE Ratio
14.87
Stock Price
428.96
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 136.61B, an increase of 3,522.79%. That is a compound annual growth rate of 12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 132.85B | 7.03% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 117.50B |
| The Searle Company | 75.04B |
| AGP Limited | 60.27B |
| Highnoon Laboratories | 54.52B |
| Shifa International Hospitals | 34.67B |
| Citi Pharma | 19.38B |
| Ferozsons Laboratories | 18.04B |
| Macter International | 15.39B |